Cardiac angiogenesis directed by stable Hypoxia Inducible Factor-1

Vascular Cell

Volumn 5, Issue 1, 2013, Pages

  Walton, Chad B ^a   Ecker, Jennifer ^a   Anderson, Cynthia D ^a   Outten, Joel T ^a   Allison, Randall Z ^a   Shohet, Ralph V ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Angiogenesis; Cardiac; HIF 1; Perfusion

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; NOTCH1 RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RESIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CARDIOMEGALY; CONTROLLED STUDY; ERYTHROCYTE VOLUME; HEART; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; VASCULARIZATION; WESTERN BLOTTING;

MUS MUSCULUS;

EID: 84883110089     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-5-15     Document Type: Article

References (21)

1. Regulation of angiogenesis by hypoxia: role of the HIF system. Pugh CW, Ratcliffe PJ, Nat Med 2003 9 6 677 84 10.1038/nm0603-677 12778166 (Pubitemid 36749216)
2. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Wang GL, Jiang BH, Rue EA, Semenza GL, Proc Natl Acad Sci U S A 1995 92 12 5510 4 10.1073/pnas.92.12.5510 7539918
3. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE, Proc Natl Acad Sci U S A 1991 88 13 5680 4 10.1073/pnas.88.13.5680 2062846 (Pubitemid 21914809)
4. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Huang LE, Gu J, Schau M, Bunn HF, Proc Natl Acad Sci USA 1998 95 14 7987 92 10.1073/pnas.95.14.7987 9653127 (Pubitemid 28326053)
5. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ, Science 2001 292 5516 468 72 10.1126/science.1059796 11292861 (Pubitemid 32335942)
6. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML, Science 2002 295 5556 858 61 10.1126/science.1068592 11823643 (Pubitemid 34118367)
7. An essential role for p300/CBP in the cellular response to hypoxia. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM, Proc Natl Acad Sci U S A 1996 93 23 12969 73 10.1073/pnas.93.23. 12969 8917528 (Pubitemid 26382753)
8. Conditional HIF-1alpha expression produces a reversible cardiomyopathy. Bekeredjian R, Walton CB, MacCannell KA, Ecker J, Kruse F, Outten JT, Sutcliffe D, Gerard RD, Bruick RK, Shohet RV, PLoS One 2010 5 7 11693 10.1371/journal. pone.0011693 20657781
9. New polyurethane-based material for vascular corrosion casting with improved physical and imaging characteristics. Krucker T, Lang A, Meyer EP, Microsc Res Tech 2006 69 2 138 47 10.1002/jemt.20263 16456839
10. Simple method for quantitation of enhanced vascular permeability. Udaka K, Takeuchi Y, Movat HZ, Proc Soc Exp Biol Med 1970 133 4 1384 7 10.3181/00379727-133-34695 4245399
11. Introduction to the ultrasound targeted microbubble destruction technique. Walton CB, Anderson CD, Boulay R, Shohet RV, J Vis Exp 2011 52
12. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S, Circulation 1998 97 5 473 83 10.1161/01.CIR.97.5.473 9490243 (Pubitemid 28090220)
13. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM, Curr Top Microbiol Immunol 1999 237 97 132 10.1007/978-3-642-59953-8-6 9893348 (Pubitemid 28554861)
14. Molecular mechanisms of blood vessel growth. Conway EM, Collen D, Carmeliet P, Cardiovasc Res 2001 49 3 507 21 10.1016/S0008-6363(00)00281-9 11166264 (Pubitemid 32146414)
15. Vascular endothelial growth factor (VEGF) and its receptors. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z, Faseb J 1999 13 1 9 22 9872925 (Pubitemid 29038270)
16. Oxygen sensing and molecular adaptation to hypoxia. Bunn HF, Poyton RO, Physiol Rev 1996 76 3 839 85 8757790 (Pubitemid 26286080)
17. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL, Mol Cell Biol 1996 16 9 4604 13 8756616 (Pubitemid 26272112)
18. Angiogenesis: the role of the microenvironment in flipping the switch. Giordano FJ, Johnson RS, Curr Opin Genet Dev 2001 11 1 35 40 10.1016/S0959-437X(00)00153-2 11163148 (Pubitemid 32119275)
19. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J, Circ Res 2004 94 5 664 70 10.1161/01.RES.0000118600.91698.BB 14739162 (Pubitemid 38387750)
20. Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis. Vincent KA, Feron O, Kelly RA, Trends Cardiovasc Med 2002 12 8 362 7 10.1016/S1050-1738(02)00186-X 12536123 (Pubitemid 36092127)
21. PHDs overactivation during chronic hypoxia desensitizes HIFalpha and protects cells from necrosis. Ginouves A, Ilc K, Macias N, Pouyssegur J, Berra E, Proc Natl Acad Sci USA 2008 105 12 4745 50 10.1073/pnas.0705680105 18347341 (Pubitemid 351753817)